Home > Headlines > Roche to acquire liver drug developer 89bio for up to $3.5 billion
Headlines

Roche to acquire liver drug developer 89bio for up to $3.5 billion

Published by Global Banking and Finance Review

Posted on September 18, 2025

Featured image for article about Headlines

FRANKFURT (Reuters) -Roche said on Thursday it agreed to acquire U.S. biotech firm 89bio <ETNB.O for up to $3.5 billion to strengthen its development pipeline on liver and cardiometabolic disease treatments.

In a statement, the Swiss drugmaker said the deal was worth about $2.4 billion, or up to $3.5 billion when including a non-tradeable contingent value right.

(Reporting by Ludwig Burger; Editing by Kim Coghill)

Related Posts
UK military chief urges Britain to better prepare for Russia threat
UK military chief urges Britain to better prepare for Russia threat
Ukraine hits Russian submarine in first underwater drone attack
Ukraine hits Russian submarine in first underwater drone attack
Serbia's prosecutor files to indict minister in connection with Kushner project
Serbia's prosecutor files to indict minister in connection with Kushner project
French court jails Congo ex-rebel leader for 30 years
French court jails Congo ex-rebel leader for 30 years
Italy's Caltagirone group strengthens governance procedure over Generali, MPS stakes
Italy's Caltagirone group strengthens governance procedure over Generali, MPS stakes
France says cattle disease under control as farm protests continue
France says cattle disease under control as farm protests continue
Israeli forces kill Palestinian teen in West Bank, health ministry says
Israeli forces kill Palestinian teen in West Bank, health ministry says
Peace deal gives Ukraine security guarantees similar to Article 5, official says
Peace deal gives Ukraine security guarantees similar to Article 5, official says
European drone wall, other 'flagship' defence projects at risk in EU power struggle
European drone wall, other 'flagship' defence projects at risk in EU power struggle
Jimmy Lai remains beacon of Hong Kong press freedom, say ex-colleagues awaiting his sentencing
Jimmy Lai remains beacon of Hong Kong press freedom, say ex-colleagues awaiting his sentencing
US eases sanctions on three Belarus potash companies after prisoner release
US eases sanctions on three Belarus potash companies after prisoner release
ICC rejects Israeli bid to halt Gaza war investigation
ICC rejects Israeli bid to halt Gaza war investigation
;